Caplacizumab for congenital thrombotic thrombocytopenic purpura

被引：6

作者：

Boothby, Aaron ^{[1
]}

Mazepa, Marshall ^{[1
]}

机构：

[1] Univ Minnesota, Sch Med, Dept Med, 420 Delaware St SE,MMC 480, Minneapolis, MN 55455 USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2022年 / 97卷 / 11期

关键词：

D O I：

10.1002/ajh.26693

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E420 / E421

页数：2

共 50 条

[41] How should caplacizumab be used for treatment of immune thrombotic thrombocytopenic purpura?
Zheng, Lucy
Zheng, X. Long
ANNALS OF BLOOD, 2023, 8
[42] Clinical Efficacy and Safety Profile of Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
Maqsood, Muhammad Haisum
Rubab, Kinza
Maqsood, Muhammad Zaigham
CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (07)
[43] Safety and efficacy of caplacizumab in a case of thrombotic thrombocytopenic purpura in the postpartum period
Bruzzese, Antonella
Vigna, Ernesto
Martino, Enrica Antonia
Mendicino, Francesco
Lucia, Eugenio
Olivito, Virginia
Mazzulla, Rosanna
De Rose, Silvia
Cozza, Pietro Pasquale
Bova, Carlo
Filippelli, Gianfranco
Zinno, Francesco
Morelli, Michele
Morabito, Fortunato
Gentile, Massimo
BLOOD COAGULATION & FIBRINOLYSIS, 2023, 34 (03) : 215 - 217
[44] Mortality in acquired thrombotic thrombocytopenic purpura in the pre-caplacizumab era
Julio del Río-Garma
Sabela Bobillo
Javier de la Rubia
Cristina Pascual
Faustino García-Candel
Jose M. García-Gala
Reyes Gonzalez
Laura Abril
Julia Vidan
Maria Jesús Gomez
Francisco Peña
Cristina Arbona
Jesús Martín-Sanchez
Gemma Moreno
Iñigo Romón
Aurora Viejo
Ana Oliva
Mónica Linares
Ramón Salinas
Sonia Pérez
Jose A. Garcia-Erce
Arturo Pereira
Annals of Hematology, 2022, 101 : 59 - 67
[45] Clinical pharmacology of caplacizumab for the treatment of patients with acquired thrombotic thrombocytopenic purpura
Sargentini-Maier, Maria Laura
De Decker, Philip
Tersteeg, Claudia
Canvin, Jan
Callewaert, Filip
De Winter, Hilde
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (06) : 537 - 545
[46] Cost-effectiveness of caplacizumab in immune thrombotic thrombocytopenic purpura in the United States
Sullivan, Sean D.
Chaturvedi, Shruti
Gautam, Preety
Arnaud, Alix
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2025, 31 (03): : 277 - 288
[47] Difficulties in Diagnosing Congenital Thrombotic Thrombocytopenic Purpura
Klukowska, Anna
Niewiadomska, Edyta
Budde, Ulrich
Oyen, Florian
Schneppenheim, Reinhard
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2010, 32 (02) : 103 - 107
[48] Treatment of Congenital Thrombotic Thrombocytopenic Purpura With Eculizumab
Pecoraro, Carmine
Ferretti, Alfonso Vincenzo Salvatore
Rurali, Erica
Galbusera, Miriam
Noris, Marina
Remuzzi, Giuseppe
AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (06) : 1067 - 1070
[49] Characterization and treatment of congenital thrombotic thrombocytopenic purpura
Alwan, Ferras
Vendramin, Chiara
Liesner, Ri
Clark, Amanda
Lester, William
Dutt, Tina
Thomas, William
Gooding, Richard
Biss, Tina
Watson, H. G.
Cooper, Nichola
Rayment, Rachel
Cranfield, Tanya
van Veen, Joost J.
Hill, Quentin A.
Davis, Sarah
Motwani, Jayashree
Bhatnagar, Neha
Priddee, Nicole
David, Marianna
Crowley, Maeve P.
Alamelu, Jayanthi
Lyall, Hamish
Westwood, John-Paul
Thomas, Mari
Scully, Marie
BLOOD, 2019, 133 (15) : 1644 - 1651
[50] Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter data
Gavriilaki, Eleni
Nikolousis, Emmanuel
Koravou, Eudoxia-Evaggelia
Dimou-Besikli, Sotiria
Kartsios, Charalampos
Papakonstantinou, Anna
Mpanti, Anastasia
Pontikoglou, Charalampos
Kalpadaki, Christina
Bitsani, Aikaterini
Tassi, Ilianna
Touloumenidou, Tasoula
Chatziconstantinou, Thomas
Papathanasiou, Maria
Syrigou, Antonia
Ztriva, Eleutheria
Kaiafa, Georgia
Mandala, Evdokia
Mellios, Zois
Karakasis, Dimitrios
Kourakli, Alexandra
Symeonidis, Argiris
Kapsali, Eleni
Papadaki, Helen H.
Lalayanni, Chrysavgi
Sakellari, Ioanna
FRONTIERS IN MEDICINE, 2023, 10

← 1 2 3 4 5 →